Meihua International Medical Technologies Co., Ltd. (MHUA)
USD 0.27
(-44.94%)
USD 0.27
(-44.94%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 33.09 Million USD | -12.86% |
| 2022 | 38.09 Million USD | -4.29% |
| 2021 | 39.8 Million USD | 7.12% |
| 2020 | 37.16 Million USD | 15.37% |
| 2019 | 32.21 Million USD | 1.01% |
| 2018 | 31.88 Million USD | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q2 | 7.56 Million USD | 0.0% |
| 2024 Q1 | 7.56 Million USD | -5.25% |
| 2023 Q4 | 7.98 Million USD | 0.0% |
| 2023 Q1 | 8.56 Million USD | -50.25% |
| 2023 FY | 33.19 Million USD | -12.86% |
| 2023 Q3 | 7.98 Million USD | -53.29% |
| 2023 Q2 | 17.09 Million USD | 99.76% |
| 2022 Q2 | 20.89 Million USD | 100.63% |
| 2022 FY | 38.09 Million USD | -4.29% |
| 2022 Q1 | 10.41 Million USD | -3.25% |
| 2022 Q4 | 17.2 Million USD | 100.75% |
| 2022 Q3 | 8.57 Million USD | -58.97% |
| 2021 Q4 | 10.76 Million USD | 0.7% |
| 2021 Q3 | 10.68 Million USD | 17.29% |
| 2021 Q2 | 9.11 Million USD | 0.0% |
| 2021 Q1 | 9.11 Million USD | 1.49% |
| 2021 FY | 39.8 Million USD | 7.12% |
| 2020 Q2 | 9.52 Million USD | 0.0% |
| 2020 FY | 37.16 Million USD | 15.37% |
| 2020 Q4 | 8.97 Million USD | 0.0% |
| 2020 Q3 | 8.97 Million USD | -5.73% |
| 2020 Q1 | 9.52 Million USD | 45.11% |
| 2019 Q1 | 9.45 Million USD | 0.0% |
| 2019 Q4 | 6.56 Million USD | 0.0% |
| 2019 Q3 | 6.56 Million USD | -30.59% |
| 2019 Q2 | 9.45 Million USD | 0.0% |
| 2019 FY | 32.21 Million USD | 1.01% |
| 2018 FY | 31.88 Million USD | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| Akoya Biosciences, Inc. | 56.3 Million USD | 41.222% |
| AngioDynamics, Inc. | 154.69 Million USD | 78.607% |
| AtriCure, Inc. | 300.37 Million USD | 88.982% |
| Avinger, Inc. | 2 Million USD | -1552.272% |
| Azenta, Inc. | 263.14 Million USD | 87.423% |
| BioLife Solutions, Inc. | 46.75 Million USD | 29.212% |
| The Cooper Companies, Inc. | 2.35 Billion USD | 98.596% |
| Daxor Corporation | 1.1 Million USD | -2899.257% |
| Ekso Bionics Holdings, Inc. | 9.07 Million USD | -264.523% |
| Femasys Inc. | 691.9 Thousand USD | -4683.199% |
| GlucoTrack, Inc. | -13 Thousand USD | 254676.938% |
| Harvard Bioscience, Inc. | 60.86 Million USD | 45.626% |
| Hologic, Inc. | 2.22 Billion USD | 98.514% |
| ICU Medical, Inc. | 739.87 Million USD | 95.527% |
| Intuitive Surgical, Inc. | 4.72 Billion USD | 99.3% |
| KORU Medical Systems, Inc. | 16.7 Million USD | -98.075% |
| LeMaitre Vascular, Inc. | 127.04 Million USD | 73.951% |
| Innovative Eyewear, Inc. | -119.32 Thousand USD | 27834.249% |
| Innovative Eyewear, Inc. | -119.32 Thousand USD | 27834.249% |
| Masimo Corporation | 1 Billion USD | 96.702% |
| Microbot Medical Inc. | -106 Thousand USD | 31321.7% |
| Merit Medical Systems, Inc. | 583.87 Million USD | 94.332% |
| Nephros, Inc. | 8.4 Million USD | -293.754% |
| NovoCure Limited | 381.05 Million USD | 91.315% |
| NEXGEL, Inc. | 619 Thousand USD | -5246.527% |
| NEXGEL, Inc. | 619 Thousand USD | -5246.527% |
| Singular Genomics Systems, Inc. | -558 Thousand USD | 6031.004% |
| OraSure Technologies, Inc. | 179.42 Million USD | 81.555% |
| Pro-Dex, Inc. | 14.55 Million USD | -127.441% |
| Pulse Biosciences, Inc. | -1.2 Million USD | 2841.922% |
| Predictive Oncology Inc. | 1.14 Million USD | -2789.644% |
| Precision Optics Corporation, Inc. | 5.79 Million USD | -470.822% |
| QuidelOrtho Corporation | 1.49 Billion USD | 97.785% |
| Repligen Corporation | 315.22 Million USD | 89.501% |
| Sanara MedTech Inc. | 57.13 Million USD | 42.078% |
| STAAR Surgical Company | 252.65 Million USD | 86.901% |
| Sharps Technology, Inc. | -891.24 Thousand USD | 3813.333% |
| Utah Medical Products, Inc. | 30.03 Million USD | -10.177% |
| DENTSPLY SIRONA Inc. | 2.08 Billion USD | 98.413% |
| Jin Medical International Ltd. | 6.78 Million USD | -387.779% |